339 related articles for article (PubMed ID: 12885756)
1. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
Rother E; Brandl R; Baker DL; Goyal P; Gebhard H; Tigyi G; Siess W
Circulation; 2003 Aug; 108(6):741-7. PubMed ID: 12885756
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.
Khandoga AL; Fujiwara Y; Goyal P; Pandey D; Tsukahara R; Bolen A; Guo H; Wilke N; Liu J; Valentine WJ; Durgam GG; Miller DD; Jiang G; Prestwich GD; Tigyi G; Siess W
Platelets; 2008 Sep; 19(6):415-27. PubMed ID: 18925509
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid is the unique platelet-activating substance in human malignant ascites.
Sandmann G; Siess W; Essler M
Eur J Med Res; 2003 Sep; 8(9):397-404. PubMed ID: 14555295
[TBL] [Abstract][Full Text] [Related]
4. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
Tokumura A; Sinomiya J; Kishimoto S; Tanaka T; Kogure K; Sugiura T; Satouchi K; Waku K; Fukuzawa K
Biochem J; 2002 Aug; 365(Pt 3):617-28. PubMed ID: 11982483
[TBL] [Abstract][Full Text] [Related]
5. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
Ohta H; Sato K; Murata N; Damirin A; Malchinkhuu E; Kon J; Kimura T; Tobo M; Yamazaki Y; Watanabe T; Yagi M; Sato M; Suzuki R; Murooka H; Sakai T; Nishitoba T; Im DS; Nochi H; Tamoto K; Tomura H; Okajima F
Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
[TBL] [Abstract][Full Text] [Related]
6. Thrombogenic and atherogenic activities of lysophosphatidic acid.
Siess W; Tigyi G
J Cell Biochem; 2004 Aug; 92(6):1086-94. PubMed ID: 15258894
[TBL] [Abstract][Full Text] [Related]
7. Synergistic activation of human platelets by lysophosphatidic acid and adrenaline.
Nilsson U; Svensson SP; Grenegård M
Haematologica; 2002 Jul; 87(7):730-9; discussion 739. PubMed ID: 12091124
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation.
Gueguen G; Gaigé B; Grévy JM; Rogalle P; Bellan J; Wilson M; Klaébé A; Pont F; Simon MF; Chap H
Biochemistry; 1999 Jun; 38(26):8440-50. PubMed ID: 10387090
[TBL] [Abstract][Full Text] [Related]
9. The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors.
Haserück N; Erl W; Pandey D; Tigyi G; Ohlmann P; Ravanat C; Gachet C; Siess W
Blood; 2004 Apr; 103(7):2585-92. PubMed ID: 14645014
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acids. II. Interaction of the effects of adenosine diphosphate and lysophosphatidic acids in dog, rabbit, and human platelets.
Gerrard JM; Kindom SE; Peterson DA; White JG
Am J Pathol; 1979 Dec; 97(3):531-47. PubMed ID: 315721
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands.
Durgam GG; Tsukahara R; Makarova N; Walker MD; Fujiwara Y; Pigg KR; Baker DL; Sardar VM; Parrill AL; Tigyi G; Miller DD
Bioorg Med Chem Lett; 2006 Feb; 16(3):633-40. PubMed ID: 16263282
[TBL] [Abstract][Full Text] [Related]
12. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
[TBL] [Abstract][Full Text] [Related]
13. Short-chain phosphatidates are subtype-selective antagonists of lysophosphatidic acid receptors.
Fischer DJ; Nusser N; Virag T; Yokoyama K; Wang Da ; Baker DL; Bautista D; Parrill AL; Tigyi G
Mol Pharmacol; 2001 Oct; 60(4):776-84. PubMed ID: 11562440
[TBL] [Abstract][Full Text] [Related]
14. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
[TBL] [Abstract][Full Text] [Related]
15. Propofol inhibits human platelet aggregation induced by proinflammatory lipid mediators.
Fourcade O; Simon MF; Litt L; Samii K; Chap H
Anesth Analg; 2004 Aug; 99(2):393-8, table of contents. PubMed ID: 15271713
[TBL] [Abstract][Full Text] [Related]
16. Neurotransmitter release from lysophosphatidic acid stimulated PC12 cells: involvement of lysophosphatidic acid receptors.
Shiono S; Kawamoto K; Yoshida N; Kondo T; Inagami T
Biochem Biophys Res Commun; 1993 Jun; 193(2):667-73. PubMed ID: 8390248
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid induces human natural killer cell chemotaxis and intracellular calcium mobilization.
Jin Y; Knudsen E; Wang L; Maghazachi AA
Eur J Immunol; 2003 Aug; 33(8):2083-9. PubMed ID: 12884281
[TBL] [Abstract][Full Text] [Related]
18. Phosphonothioate and fluoromethylene phosphonate analogues of cyclic phosphatidic acid: Novel antagonists of lysophosphatidic acid receptors.
Xu Y; Jiang G; Tsukahara R; Fujiwara Y; Tigyi G; Prestwich GD
J Med Chem; 2006 Aug; 49(17):5309-15. PubMed ID: 16913720
[TBL] [Abstract][Full Text] [Related]
19. Initial structure-activity relationships of lysophosphatidic acid receptor antagonists: discovery of a high-affinity LPA1/LPA3 receptor antagonist.
Heasley BH; Jarosz R; Lynch KR; Macdonald TL
Bioorg Med Chem Lett; 2004 Jun; 14(11):2735-40. PubMed ID: 15125924
[TBL] [Abstract][Full Text] [Related]
20. Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets.
Minuz P; Fumagalli L; Gaino S; Tommasoli RM; Degan M; Cavallini C; Lecchi A; Cattaneo M; Lechi Santonastaso C; Berton G
Biochem J; 2006 Nov; 400(1):127-34. PubMed ID: 16859489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
